Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company... Show more
The Moving Average Convergence Divergence (MACD) for PAHC turned positive on October 20, 2025. Looking at past instances where PAHC's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on October 17, 2025. You may want to consider a long position or call options on PAHC as a result. In of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PAHC advanced for three days, in of 286 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PAHC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
PAHC broke above its upper Bollinger Band on October 21, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for PAHC entered a downward trend on October 16, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.882) is normal, around the industry mean (17.901). P/E Ratio (34.832) is within average values for comparable stocks, (73.179). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.086). PAHC has a moderately low Dividend Yield (0.012) as compared to the industry average of (0.031). P/S Ratio (1.301) is also within normal values, averaging (48.686).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PAHC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
a manufacturer of animal health pharmaceutical and nutritional products
Industry PharmaceuticalsGeneric
A.I.dvisor indicates that over the last year, PAHC has been loosely correlated with AMRX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if PAHC jumps, then AMRX could also see price increases.
Ticker / NAME | Correlation To PAHC | 1D Price Change % | ||
---|---|---|---|---|
PAHC | 100% | +2.04% | ||
AMRX - PAHC | 46% Loosely correlated | +0.49% | ||
ZTS - PAHC | 42% Loosely correlated | +0.71% | ||
ELAN - PAHC | 41% Loosely correlated | -0.46% | ||
PBH - PAHC | 40% Loosely correlated | +0.50% | ||
VTRS - PAHC | 38% Loosely correlated | +0.78% | ||
More |
Ticker / NAME | Correlation To PAHC | 1D Price Change % |
---|---|---|
PAHC | 100% | +2.04% |
Pharmaceuticals: Generic industry (217 stocks) | 40% Loosely correlated | -0.66% |